Maravai LifeSciences Holdings, Inc.
MRVI
Maravai LifeSciences Holdings, Inc., a life sciences company, provides products to enable the development of drug therapies, diagnostics, novel vaccines, and support research on human diseases in the United States and internationally. The company's products address the key phases of biopharmaceutical development and include nucleic acids for diagnostic and therapeutic applications, antibody-basedā¦ read more
Healthcare
Biotechnology
5 years
USD
Exclusive to Premium users
Price
per share adjusted in USD$3.42
Price+5.08%
$0.17
1Y
Price
Market Cap
$942.574m
Small
Price/Earnings 3y Avg5y Avg
-
Premium
Premium
Financial Reports
Key metrics over the past few years and other important metrics. Amounts in USD.-54.0%
EBITDA Margin-61.4%
Net Profit Margin-43.4%
Free Cash Flow Margin-54.0%
EBITDA Margin-61.4%
Net Profit Margin-43.4%
Free Cash Flow MarginRevenue
$192.283m
-25.8%
1y CAGR-34.5%
3y CAGR-23.2%
5y CAGREarnings
-$121.237m
+16.3%
1y CAGR-53.1%
3y CAGR-34.6%
5y CAGREPS
-$0.18
+82.9%
1y CAGR-29.2%
3y CAGR-20.2%
5y CAGRBook Value
$431.859m
$849.191m
Assets$417.332m
Liabilities$35.847m
DebtDebt to Assets
4.2%
-0.3x
Debt to EBITDAFree Cash Flow
-$66.327m
-198.9%
1y CAGR-141.2%
3y CAGR-94.3%
5y CAGRNo items found.
Press Releases
Statements and updates from the company